EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications

Shweta Mishra, Chetna Jadala, Savio Cardoza, Gal Reddy Potuganti iD, Ganga Reddy Velma iD

RSC Advances · 2026 · 16 (15) · 13830-13850

DOI: 10.1039/d6ra01711h ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RSC Advances, 2026. Verfasst von Shweta Mishra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research Sant Tukaram Nagar, Pimpri Pune 411018 India. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorine has been widely incorporated into small-molecule drugs as an effective strategy to modulate metabolic stability, lipophilicity, target interactions, and overall pharmacokinetic profile.

Autor:innen und Institutionen

  • Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research Sant Tukaram Nagar, Pimpri Pune 411018 India.
  • DPGU-School of Pharmacy and Research Sant Tukaram Nagar, Pimpri Pune 411018 India.
  • Indiana University School of Medicine, Indiana University (IU) Indianapolis IN 46202 USA.
  • Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Tucson AZ 85721 USA vgreddy@arizona.edu velmagangareddy47@gmail.com.
  • Department of Chemistry and Biochemistry, The University of Oklahoma Norman Oklahoma 73019 USA.

ORCID-Profile: Gal Reddy Potuganti, Ganga Reddy Velma

Zitieren

APA

Mishra, S., Jadala, C., Cardoza, S., Potuganti, G. R., & Velma, G. R. (2026). Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications. RSC Advances, 16(15), 13830-13850. https://doi.org/10.1039/d6ra01711h

Vancouver

Mishra S, Jadala C, Cardoza S, Potuganti GR, Velma GR. Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications. RSC Advances. 2026;16(15):13830-13850. doi:10.1039/d6ra01711h

BibTeX
@article{Mishra2026,
  author = {Mishra, Shweta and Jadala, Chetna and Cardoza, Savio and Potuganti, Gal Reddy and Velma, Ganga Reddy},
  title = {Fluorine-containing FDA-approved small-molecule drugs in 2025: significance, synthetic insights, and therapeutic applications},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {15},
  pages = {13830--13850},
  doi = {10.1039/d6ra01711h}
}
Kostenlos starten →